>
BREAKING EXCLUSIVE: The Iran War Is Being Used By The Deep State...
"It makes no sense!" Bombing Iran has been a DISASTER
Anthropic Outpaces OpenAI Revenue 10X, Pentagon vs. Dario, Agents Rent Humans | #234
Everyone keeps asking why ships are sitting idle outside the Strait of Hormuz.
US particle accelerators turn nuclear waste into electricity, cut radioactive life by 99.7%
Blast Them: A Rutgers Scientist Uses Lasers to Kill Weeds
H100 GPUs that cost $40,000 new are now selling for around $6,000 on eBay, an 85% drop.
We finally know exactly why spider silk is stronger than steel.
She ran out of options at 12. Then her own cells came back to save her.
A cardiovascular revolution is silently unfolding in cardiac intervention labs.
DARPA chooses two to develop insect-size robots for complex jobs like disaster relief...
Multimaterial 3D printer builds fully functional electric motor from scratch in hours
WindRunner: The largest cargo aircraft ever to be built, capable of carrying six Chinooks

The US processed-food industrial complex, partly controlled by globalist mega-corps, is beginning to reckon with a new reality: Make America Healthy Again and rising weight-loss drug use are reshaping what Americans eat - and what they're walking away from, mostly junk food loaded with toxic seed oils, as well as alcohol.
In the coming weeks, Robert F. Kennedy Jr., President Donald Trump's Health and Human Services (HHS) Secretary, will be releasing new dietary guidelines to reset America's food supply chain away from toxic seed oils and highly processed foods toward real food. This is part of the MAHA trend.
MAHA, combined with the expected surge in GLP-1 demand (thanks to Trump's deal with Novo Nordisk and Lilly to cut costs), is likely to wipe out tens of billions in food and beverage sales in the coming years.
Bloomberg Intelligence analysts Jibril Lawal and Jennifer Bartashus forecast that the rapid adoption of GLP-1 weight-loss drugs will reduce US and European food and beverage sales by $53 billion by 2035.
Weight-loss drugs are reshaping consumption, and our analysis shows GLP-1s are set to erase $53 billion in food and beverage sales by 2035. Volume losses will be steepest in snacks, baked goods and confectionery -- a 4-6% sales drag in the US and 3-5% in Europe. Alcohol also faces a 2-4% drop as consumers shift to healthier options. -Lawal
Here are the key takeaways from the report that only suggest a coming food revolution across the West:
1. GLP-1s Could Cut Food, Beverage Sales by Billions
The adoption of GLP-1 drugs will significantly reduce US and European food and beverage consumption if uptake reaches 19.5% and 13.1% of the adolescent and adult population (ages 12-65+) by 2035, BI's high-end scenario analysis shows. Our model isolates volume impact only and excludes pricing increases or reformulations that might o?set lower consumption. Under these assumptions, baked-goods sales are expected to drop by $11.5 billion and confectionery $8 billion -- the largest food declines -- while beer and spirits may fall by $12.5 billion and $9.2 billion, the steepest beverage contractions. Concurrently, we anticipate demand to shift toward healthier alternatives, with bottled water, fruits and vegetables each gaining more than $4 billion over the period.